| The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
159 |
| Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang |
22 |
| microRNA-21 and hypertension |
18 |
| Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease |
17 |
| Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease |
13 |
| Hypertension with diabetes mellitus: physiology and pathology |
12 |
| Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial |
11 |
| Hypertension with diabetes mellitus complications |
11 |
| Circular RNAs in hypertension: challenges and clinical promise |
11 |
| Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension |
10 |
| Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension |
9 |
| Neutrophil to lymphocyte ratio as predictor for incident hypertension: a 9-year cohort study in Taiwan |
9 |
| Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice |
9 |
| Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications |
9 |
| Urinary sodium excretion and risk of cardiovascular disease in the Chinese population: a prospective study |
9 |
| Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples |
8 |
| Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study |
8 |
| Urinary sodium-to-potassium ratio and intake of sodium and potassium among men and women from multiethnic general populations: the INTERSALT Study |
7 |
| High blood pressure and its relationship to adiposity in a school-aged population: body mass index vs waist circumference |
7 |
| Baroreflex failure and beat-to-beat blood pressure variation |
7 |
| Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure |
7 |
| The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney |
7 |
| Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism |
7 |
| Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population |
7 |
| Changing views on the common physiologic abnormality that mediates salt sensitivity and initiation of salt-induced hypertension: Japanese research underpinning the vasodysfunction theory of salt sensitivity |
7 |
| Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation |
7 |
| Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension |
7 |
| Comparison of blood pressure values-self-measured at home, measured at an unattended office, and measured at a conventional attended office |
7 |
| Mechanisms of action of Panax notoginseng ethanolic extract for its vasodilatory effects and partial characterization of vasoactive compounds |
6 |
| Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats |
6 |
| Epigenetic modification: a regulatory mechanism in essential hypertension |
6 |
| Association of cigarette smoking with radial augmentation index: the Circulatory Risk in Communities Study (CIRCS) |
6 |
| Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials |
6 |
| Markers of subclinical vascular damages associate with indices of adiposity and blood pressure in obese children |
6 |
| Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs |
6 |
| Effects of uric acid on vascular endothelial function from bedside to bench |
6 |
| Seasonal blood pressure variation: implications for cardiovascular risk stratification |
6 |
| Microcirculation and biomarkers in patients with resistant or mild-to-moderate hypertension: a cross-sectional study |
6 |
| Implications of blood pressure variations in older populations |
6 |
| The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females |
6 |
| Association between alcohol consumption during pregnancy and hypertensive disorders of pregnancy in Japan: the Japan Environment and Children's Study |
6 |
| Diurnal blood pressure changes |
6 |
| The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review |
6 |
| Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients |
6 |
| Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study |
6 |
| Aortic stiffness improves the prediction of both diagnosis and severity of coronary artery disease |
6 |
| Hypertensive disorders of pregnancy: a strong risk factor for subsequent hypertension 5 years after delivery |
6 |
| Examination of the associations between m(6)A-associated single-nucleotide polymorphisms and blood pressure |
6 |
| Seasonal variation in nocturnal home blood pressure fall: the Nagahama study |
6 |
| Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice |
5 |
